Skip NavigationSkip to Content

Sequencing-based functional assays for classification of BRCA2 variants in mouse ESCs

  1. Author:
    Biswas,Kajal
    Mitrophanov,Alex
    Sahu,Sounak
    Sullivan,Teresa
    Southon,Eileen
    Nousome,Darryl
    Reid, Susan
    Narula, Sakshi
    Smolen, Julia
    Sengupta, Trisha
    Riedel-Topper, Maximilian
    Kapoor, Medha
    Babbar, Anav
    Stauffer,Stacey
    Cleveland, Linda
    Tandon, Mayank
    Malys,Tyler
    Sharan,Shyam
  2. Author Address

    Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD 21702, USA., Statistical Consulting and Scientific Programming, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA., Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD 21702, USA; Leidos Biomed Research Inc., Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA., Biomedical Informatics and Data Science, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA., Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD 21702, USA. Electronic address: sharans@mail.nih.gov.,
    1. Year: 2023
    2. Date: Nov 20
    3. Epub Date: 2023 10 31
  1. Journal: Cell Reports Methods
    1. 3
    2. 11
    3. Pages: 100628
  2. Type of Article: Article
  3. Article Number: 100628
  1. Abstract:

    Sequencing of genes, such as BRCA1 and BRCA2, is recommended for individuals with a personal or family history of early onset and/or bilateral breast and/or ovarian cancer or a history of male breast cancer. Such sequencing efforts have resulted in the identification of more than 17,000 BRCA2 variants. The functional significance of most variants remains unknown; consequently, they are called variants of uncertain clinical significance (VUSs). We have previously developed mouse embryonic stem cell (mESC)-based assays for functional classification of BRCA2 variants. We now developed a next-generation sequencing (NGS)-based approach for functional evaluation of BRCA2 variants using pools of mESCs expressing 10-25 BRCA2 variants from a given exon. We use this approach for functional evaluation of 223 variants listed in ClinVar. Our functional classification of BRCA2 variants is concordant with the classification reported in ClinVar or those reported by other orthogonal assays. Published by Elsevier Inc.

    See More

External Sources

  1. DOI: 10.1016/j.crmeth.2023.100628
  2. PMID: 37922907
  3. PMCID: PMC10694496
  4. WOS: 001121163900001
  5. PII : S2667-2375(23)00292-8

Library Notes

  1. Fiscal Year: FY2023-2024
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel